Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey. (2021)

First Author: Hüls A

Attributed to: Neuropathological and amyloid peptide differences between DS and familial AD with duplications and missense mutations in APP gene funded by MRC

No abstract provided

PubMed Identifier: 33644721

Type: Journal Article/Review

Volume: 33

Parent Publication: EClinicalMedicine

ISSN: 2589-5370